欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3211/001
药品名称Brabio 20 mg/ml solution for injection, pre-filled syringe
活性成分
    • glatiramer acetate 20.0 mg/ml
剂型Solution for injection in prefilled syringe
上市许可持有人Synthon BV Microweg 22 Nijmegen The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Brabio 20 mg/ml, oplossing voor injectie in een voorgevulde spuit
互认成员国 - 产品名称
    • Denmark (DK)
      Copemyl
    • Iceland (IS)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Greece (GR)
      BRABIO (ex GLATIRAMER ACETATE/ACTAVIS)
    • Sweden (SE)
    • Norway (NO)
      Brabio
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Remurel 20 mg/ml šķīdums injekcijām pilnšļircē
    • Lithuania (LT)
      Remurel 20 mg/ml injekcinis tirpalas užpildytame švirkšte
    • Estonia (EE)
      REMUREL
    • Hungary (HU)
      REMUREL 20 mg/ml oldatos injekció előretöltött fecskendőben
    • Bulgaria (BG)
      Remurel
    • Cyprus (CY)
    • Czechia (CZ)
      BRABIO 20 MG/ML INJEKČNÍ ROZTOK V PŘEDPLNĚNÉ INJEKČNÍ STŘÍKAČCE
    • Romania (RO)
    • Slovakia (SK)
      Brabio 20 mg/ml
    • Slovenia (SI)
    • Croatia (HR)
      Remurel 20 mg/ml otopina za injekciju u napunjenoj štrcaljki
许可日期2016/03/11
最近更新日期2024/04/04
药物ATC编码
    • L03AX13 glatiramer acetate
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase